Endocrine Disruptors and Polycystic Ovary Syndrome: Phthalates
Leyla AkınMustafa KendirciFigen NarinSelim KurtogluNihal HatipogluFerhan ElmalıPublished in: Journal of clinical research in pediatric endocrinology (2020)
Serum DEHP and MEHP concentrations were not different between adolescents with or without PCOS. However, these phthalates are associated with metabolic disturbances such as dyslipidemia and insulin resistance, independently of obesity, in girls with PCOS.